BR9805993B1 - composição farmacêutica de aerossol. - Google Patents

composição farmacêutica de aerossol.

Info

Publication number
BR9805993B1
BR9805993B1 BRPI9805993-9A BR9805993A BR9805993B1 BR 9805993 B1 BR9805993 B1 BR 9805993B1 BR 9805993 A BR9805993 A BR 9805993A BR 9805993 B1 BR9805993 B1 BR 9805993B1
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
aerosol pharmaceutical
aerosol
composition
pharmaceutical
Prior art date
Application number
BRPI9805993-9A
Other languages
English (en)
Portuguese (pt)
Other versions
BR9805993A (pt
Inventor
David Lewis
David Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9805993(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR9805993A publication Critical patent/BR9805993A/pt
Publication of BR9805993B1 publication Critical patent/BR9805993B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI9805993-9A 1997-06-13 1998-06-10 composição farmacêutica de aerossol. BR9805993B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (2)

Publication Number Publication Date
BR9805993A BR9805993A (pt) 1999-08-31
BR9805993B1 true BR9805993B1 (pt) 2009-05-05

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9805993-9A BR9805993B1 (pt) 1997-06-13 1998-06-10 composição farmacêutica de aerossol.

Country Status (44)

Country Link
EP (2) EP0920302B2 (enExample)
JP (1) JP4380802B2 (enExample)
KR (1) KR100546239B1 (enExample)
CN (1) CN1138532C (enExample)
AR (1) AR012977A1 (enExample)
AT (1) ATE222751T1 (enExample)
AU (1) AU729966B2 (enExample)
BG (1) BG63906B1 (enExample)
BR (1) BR9805993B1 (enExample)
CA (1) CA2263445C (enExample)
CO (1) CO4940408A1 (enExample)
CZ (1) CZ295521B6 (enExample)
DE (1) DE69807420T3 (enExample)
DK (1) DK0920302T4 (enExample)
DZ (1) DZ2516A1 (enExample)
EA (1) EA001259B1 (enExample)
EE (1) EE03664B1 (enExample)
ES (1) ES2182351T5 (enExample)
GB (1) GB2326334A (enExample)
GE (1) GEP20012462B (enExample)
HR (1) HRP980317B1 (enExample)
HU (1) HU228487B1 (enExample)
ID (1) ID21491A (enExample)
IL (1) IL128484A (enExample)
IN (1) IN189317B (enExample)
IS (1) IS2435B (enExample)
IT (1) IT1293803B1 (enExample)
MA (1) MA26507A1 (enExample)
ME (2) ME00333B (enExample)
MY (1) MY119074A (enExample)
NO (1) NO327775B1 (enExample)
NZ (1) NZ334149A (enExample)
PL (1) PL193721B1 (enExample)
PT (1) PT920302E (enExample)
RS (1) RS51274B (enExample)
SA (1) SA98190821B1 (enExample)
SI (1) SI0920302T2 (enExample)
SK (1) SK284430B6 (enExample)
TN (1) TNSN98087A1 (enExample)
TR (1) TR199900288T1 (enExample)
TW (1) TW555570B (enExample)
UA (1) UA70289C2 (enExample)
WO (1) WO1998056349A1 (enExample)
ZA (1) ZA985136B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
HU230804B1 (hu) 2000-05-22 2018-06-28 Chiesi Farmaceutici S.P.A Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ATE267591T1 (de) 2001-07-02 2004-06-15 Chiesi Farma Spa Optimierte tobramycin-formulierung zur aerosolbildung
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
LT3384931T (lt) 2002-03-01 2019-09-25 Chiesi Farmaceutici S.P.A. Ypatingai smulki formoterolio kompozicija
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
JP2006516545A (ja) * 2003-02-04 2006-07-06 クリサリス テクノロジーズ インコーポレイテッド パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法
JP4708332B2 (ja) 2003-03-20 2011-06-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 推進剤としてヒドロフルオロアルカンを用いる計量式吸入器のための調合物
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CA2571519C (en) 2004-07-02 2013-05-14 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2217278A1 (en) * 2007-11-07 2010-08-18 AstraZeneca AB Dry powder formulations comprising ascorbic acid derivates
CN105854136A (zh) * 2010-09-06 2016-08-17 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
IL265349B2 (en) * 2016-09-19 2023-03-01 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71520T1 (de) † 1986-03-10 1992-02-15 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
EP0259383B1 (de) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Pharmazeutikum sowie verfahren zu seiner herstellung
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
CA2094266C (en) † 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
CA2111002C (en) † 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
IL102130A0 (en) † 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
ATE204743T1 (de) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
RO117414B1 (ro) * 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
ES2244008T3 (es) † 1996-12-04 2005-12-01 Link Products Limited Composiciones farmaceuticas y dispositivos para su administracion.
PT1014943E (pt) † 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois

Also Published As

Publication number Publication date
PT920302E (pt) 2002-11-29
KR20000068171A (ko) 2000-11-25
CN1138532C (zh) 2004-02-18
TR199900288T1 (xx) 1999-09-21
EE03664B1 (et) 2002-04-15
EA199900201A1 (ru) 1999-06-24
HUP0001339A3 (en) 2000-10-30
DK0920302T4 (da) 2006-10-09
DK0920302T3 (da) 2002-12-23
GEP20012462B (en) 2001-06-25
GB2326334A (en) 1998-12-23
NO990594L (no) 1999-04-13
CA2263445A1 (en) 1998-12-17
ES2182351T5 (es) 2007-03-16
EP0920302B1 (en) 2002-08-28
CZ46299A3 (cs) 1999-07-14
AR012977A1 (es) 2000-11-22
CA2263445C (en) 2008-09-09
TW555570B (en) 2003-10-01
HRP980317B1 (en) 2002-06-30
ITMI971798A1 (it) 1999-01-28
CZ295521B6 (cs) 2005-08-17
NZ334149A (en) 2000-07-28
EE9900055A (et) 1999-08-16
KR100546239B1 (ko) 2006-01-26
BG103221A (en) 1999-09-30
RS51274B (sr) 2010-12-31
EP1219293A2 (en) 2002-07-03
EP0920302B2 (en) 2006-06-21
EP0920302A1 (en) 1999-06-09
YU6999A (sh) 2000-03-21
EP1219293A3 (en) 2003-05-28
DE69807420T2 (de) 2003-05-08
DE69807420D1 (de) 2002-10-02
PL331531A1 (en) 1999-07-19
SK17699A3 (en) 1999-07-12
SK284430B6 (sk) 2005-04-01
ME00333B (me) 2011-02-10
BR9805993A (pt) 1999-08-31
EA001259B1 (ru) 2000-12-25
NO327775B1 (no) 2009-09-21
DE69807420T3 (de) 2006-11-16
TNSN98087A1 (fr) 2005-03-15
SI0920302T1 (en) 2002-12-31
ID21491A (id) 1999-06-17
IL128484A0 (en) 2000-01-31
ZA985136B (en) 1999-01-07
MA26507A1 (fr) 2004-12-20
ES2182351T3 (es) 2003-03-01
PL193721B1 (pl) 2007-03-30
AU729966B2 (en) 2001-02-15
IS2435B (is) 2008-10-15
DZ2516A1 (fr) 2004-11-08
JP2000516965A (ja) 2000-12-19
HRP980317A2 (en) 1999-04-30
SI0920302T2 (sl) 2006-10-31
CO4940408A1 (es) 2000-07-24
CN1229355A (zh) 1999-09-22
HU228487B1 (en) 2013-03-28
AU8626298A (en) 1998-12-30
JP4380802B2 (ja) 2009-12-09
HUP0001339A2 (hu) 2000-09-28
UA70289C2 (uk) 2004-10-15
IL128484A (en) 2004-09-27
NO990594D0 (no) 1999-02-09
IS4974A (is) 1999-02-11
WO1998056349A1 (en) 1998-12-17
IN189317B (enExample) 2003-02-08
ATE222751T1 (de) 2002-09-15
MEP44008A (en) 2011-02-10
IT1293803B1 (it) 1999-03-10
HK1022271A1 (en) 2000-08-04
GB9712434D0 (en) 1997-08-13
SA98190821B1 (ar) 2006-11-19
MY119074A (en) 2005-03-31
BG63906B1 (bg) 2003-06-30

Similar Documents

Publication Publication Date Title
BR9805993B1 (pt) composição farmacêutica de aerossol.
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
NO20005218L (no) Farmasöytisk aerosolpreparat
TR199901077A3 (tr) Ispençiyari formülasyonlar.
ID27415A (id) Komposisi farmaseutik
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
ID29262A (id) Komposisi farmasi
ID27201A (id) Komposisi farmasi
ZA989680B (en) Pharmaceutical composition.
ID29294A (id) Komposisi farmasi
ZA987392B (en) Pharmaceutical composition.
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ID26215A (id) Komposisi farmasi
ITMI962628A0 (it) Composizione farmaceutica
ID23531A (id) Komposisi farmasi
DK1037604T3 (da) Farmaceutiske aerosolsammensætninger
PT1041984E (pt) Composicao farmaceutica bebivel
BR1100755A (pt) composição farmacêutica
ZA982367B (en) Pharmaceutical compositions.
TR199500776A2 (tr) Farmasötik bilesimler.
ES1038714Y (es) Dispensador de palillos de dientes.
ID17133A (id) Komposisi farmasi
SE9601854D0 (sv) Farmaceutisk komposition
SE9604299D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent
B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI NO 52400.115898/2018-48 ORIGEM: 25A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO: 5002419-06.2018.4.02.5101/RJ AUTOR: GLENMARK FARMACEUTICA LTDA REU: INPI-INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL REU: CHIESI FARMACEUTICI S.P.A. DECISAO: ANTE O EXPOSTO, JULGO PROCEDENTE EM PARTE O PEDIDO DA PARTE AUTORA, NOS TERMOS DO ARTIGO 487, INCISO I, DO CPC, PARA DETERMINAR O APOSTILAMENTO DA PI9805993-9, COM A INCORPORACAO DA REINVINDICACAO 7 DE SOLUCAO A REIVINDICACAO 1, E PARA DECLARAR A NULIDADE DA PI0107730-9, POR INEXISTIR ATIVIDADE INVENTIVA.